Selecting Good 'Drug-Like' Properties to Optimize Small Molecule Blood-Brain Barrier Penetration.

作者: Paul C. Trippier

DOI: 10.2174/0929867323666160405112353

关键词:

摘要: The success rate to achieve clinical approval of drugs developed treat diseases the central nervous system (CNS) is lowest all disease indications. A large contributor this poor failure small molecules pass through blood-brain barrier (BBB), a composed capillary endothelial cells connected by tight junctions that functions extrude xenobiotics from brain. Designing be BBB penetrant has been subject intensive research and resulted in series guidelines attain best possible chances penetration. This review will analyze current state thinking ranking importance various physicochemical properties required select molecules, describe model systems determine penetration, summarize data analysis methods provide an outlook on further developments field.

参考文章(121)
Mónika Vastag, György M Keseru, Current in vitro and in silico models of blood-brain barrier penetration: a practical view. Current Opinion in Drug Discovery & Development. ,vol. 12, pp. 115- 124 ,(2009)
David E. Clark, Computational Prediction of Blood-brain Barrier Permeation Annual Reports in Medicinal Chemistry Volume 40. ,vol. 40, pp. 403- 415 ,(2005) , 10.1016/S0065-7743(05)40026-3
Praveen Ballabh, Alex Braun, Maiken Nedergaard, The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiology of Disease. ,vol. 16, pp. 1- 13 ,(2004) , 10.1016/J.NBD.2003.12.016
Cuiping Chen, Xingrong Liu, Strategies to optimize brain penetration in drug discovery. Current Opinion in Drug Discovery & Development. ,vol. 8, pp. 505- 512 ,(2005)
Istvan A Krizbai, Imola Wilhelm, Csilla Fazakas, In vitro models of the blood-brain barrier. Acta Neurobiologiae Experimentalis. ,vol. 71, pp. 113- 128 ,(2011)
Sonia Al-Qadi, Morten Schiøtt, Steen Honoré Hansen, Peter Aadal Nielsen, Lassina Badolo, An invertebrate model for CNS drug discovery: Transcriptomic and functional analysis of a mammalian P-glycoprotein ortholog. Biochimica et Biophysica Acta. ,vol. 1850, pp. 2439- 2451 ,(2015) , 10.1016/J.BBAGEN.2015.09.002
N. Joan Abbott, Alon Friedman, Overview and introduction: The blood–brain barrier in health and disease Epilepsia. ,vol. 53, pp. 1- 6 ,(2012) , 10.1111/J.1528-1167.2012.03696.X
Han van de Waterbeemd, Dennis A. Smith, Barry C. Jones, Lipophilicity in PK design: methyl, ethyl, futile. Journal of Computer-aided Molecular Design. ,vol. 15, pp. 273- 286 ,(2001) , 10.1023/A:1008192010023
Stefan Lundquist, Mila Renftel, Julien Brillault, Laurence Fenart, Roméo Cecchelli, Marie‐Pierre Dehouck, Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharmaceutical Research. ,vol. 19, pp. 976- 981 ,(2002) , 10.1023/A:1016462205267
A Kalliokoski, M Niemi, Impact of OATP transporters on pharmacokinetics British Journal of Pharmacology. ,vol. 158, pp. 693- 705 ,(2009) , 10.1111/J.1476-5381.2009.00430.X